Meredith Ian T. - 15 Feb 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP Global Chief Med Officer
Signature
/s/ Vance R. Brown, Attorney-in-fact
Issuer symbol
BSX
Transactions as of
15 Feb 2022
Net transactions value
-$14,347
Form type
4
Filing time
17 Feb 2022, 19:21:39 UTC
Previous filing
02 Feb 2022
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +1,108 +3.6% $0.000000 31,947 15 Feb 2022 Direct F1
transaction BSX Common Stock Tax liability $14,347 -326 -1% $44.01 31,621 15 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Deferred Stock Units Options Exercise $0 -1,108 -50% $0.000000 1,108 15 Feb 2022 Common Stock 1,108 Direct F1, F2
transaction BSX Restricted Stock Units Award $0 +4,525 $0.000000 4,525 16 Feb 2022 Common Stock 4,525 Direct F3, F4
transaction BSX Stock Option (Right to Buy) Award $0 +12,941 $0.000000 12,941 16 Feb 2022 Common Stock 12,941 $44.19 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
F3 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F5 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.